|
Volumn 24, Issue 5, 2001, Pages 457-462
|
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium - Folinic acid in the first-line treatment of metastatic colorectal cancer
|
Author keywords
5 Fluorouracil; Calcium folinic acid; Colorectal cancer; Phase II study; Sodium folinic acid; Weekly 24 hour infusion
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
FOLINATE CALCIUM;
FOLINATE SODIUM;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER REGRESSION;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL TRIAL;
COLORECTAL CARCINOMA;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DIARRHEA;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG INFUSION;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
OUTPATIENT;
PHASE 2 CLINICAL TRIAL;
STOMATITIS;
SURVIVAL TIME;
TIME;
TUMOR GROWTH;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HUMANS;
INFUSIONS, INTRAVENOUS;
LEUCOVORIN;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
SODIUM;
SURVIVAL RATE;
|
EID: 17944368860
PISSN: 0378584X
EISSN: None
Source Type: Journal
DOI: 10.1159/000055126 Document Type: Article |
Times cited : (17)
|
References (22)
|